FMR LLC – ‘SC 13G/A’ on 4/29/24 re: Turnstone Biologics Corp.

On:  Monday, 4/29/24, at 8:22am ET   ·   Accession #:  315066-24-1718   ·   File #:  5-94123

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Amendment to Statement of Acquisition of Beneficial Ownership by a “Passive” Investor   —   Schedule 13G   —   WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Amendment to Statement of Acquisition of               4±    14K 
                Beneficial Ownership by a "Passive" Investor                     

Document Table of Contents

SCHEDULE 13G                                                                    

Amendment No.2                                                                  
TURNSTONE BIOLOGICS CORP                                                        
COMMON STOCK                                                                    
Cusip #90042W100                                                                
Check the appropriate box to designate the rule pursuant to which this          
Schedule is filed:                                                              
[ ] Rule 13d-1(b)                                                               
[x] Rule 13d-1(c)                                                               
[ ] Rule 13d-1(d)                                                               

Cusip #90042W100                                                                
Item 1: Reporting Person - FMR LLC                                              
Item 2: (a)  [ ]                                                                
(b)  [ ]                                                        
Item 4: Delaware                                                                
Item 5: 1,385,630                                                               
Item 6: 0                                                                       
Item 7: 1,386,323                                                               
Item 8: 0                                                                       
Item 9: 1,386,323                                                               
Item 11: 5.994%                                                                 
Item 12: HC                                                                     

Cusip #90042W100                                                                
Item 1: Reporting Person - Abigail P. Johnson                                   
Item 2: (a)  [ ]                                                                
(b)  [ ]                                                        
Item 4: United States of America                                                
Item 5: 0                                                                       
Item 6: 0                                                                       
Item 7: 1,386,323                                                               
Item 8: 0                                                                       
Item 9: 1,386,323                                                               
Item 11: 5.994%                                                                 
Item 12: IN                                                                     

?                                                                               

Item 1(a). Name of Issuer:                                                      

TURNSTONE BIOLOGICS CORP                                                        
?                                                                               
Item 1(b). Address of Issuer's Principal Executive Offices:?                    

9310 ATHENA CIRCLE, SUITE 300                                                   
LA JOLLA, CA 92037                                                              
USA                                                                             
?                                                                               
Item 2(a). Name of Person Filing:                                               

FMR LLC                                                                         

Item 2(b). Address or Principal Business Office or, if None, Residence:         

245 Summer Street, Boston, Massachusetts 02210                                  

Item 2(c). Citizenship:                                                         

Not applicable                                                                  

Item 2(d). Title of Class of Securities:                                        

COMMON STOCK                                                                    

Item 2(e). CUSIP Number:                                                        

90042W100                                                                       

Item 3. Not Applicable                                                          

Item 4. Ownership                                                               

(a) Amount Beneficially Owned: 1,386,323                                        

(b) Percent of Class: 5.994%                                                    

(c) Number of shares as to which such person has:                               

(i) sole power to vote or to direct the vote: Please see the responses to       
Items 5 and 6 on the cover page                                                 

(ii) shared power to vote or to direct the vote: 0                              

(iii) sole power to dispose or to direct the disposition of: 1,386,323          

(iv) shared power to dispose or to direct the disposition of: 0                 

Item 5. Ownership of Five Percent or Less of a Class.                           

Not applicable.                                                                 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.        

One or more other persons are known to have the right to receive or the power   
to direct the receipt of dividends from, or the proceeds from the sale of, the  
COMMON STOCK of TURNSTONE BIOLOGICS CORP. No one other person's interest in     
the COMMON STOCK of TURNSTONE BIOLOGICS CORP is more than five percent of the   
total outstanding COMMON STOCK.                                                 

Item 7. Identification and Classification of the Subsidiary Which Acquired the  
Security Being Reported on By the Parent Holding Company.                       

See attached Exhibit A.                                                         

Item 8. Identification and Classification of Members of the Group.              

Not applicable.                                                                 

Item 9. Notice of Dissolution of Group.                                         

Not applicable.                                                                 

Item 10. Certifications.                                                        

????By signing below I certify that, to the best of my knowledge and belief,    
the securities referred to above were not acquired and are not held for the     
purpose of or with the effect of changing or influencing the control of the     
issuer of the securities and were not acquired and are not held in connection   
with or as a participant in any transaction having that purpose or effect.      

Signature                                                                       

After reasonable inquiry and to the best of my knowledge and belief, I certify  
that the information set forth in this statement is true, complete and          
correct.                                                                        

April 26, 2024                                                                  
Date                                                                            

/s/ Stephanie J. Brown                                                          
Signature                                                                       

Stephanie J. Brown                                                              
Duly authorized under Power of Attorney effective as of January 3, 2023, by     
and on behalf of FMR LLC and its direct and indirect subsidiaries*              

* This power of attorney is incorporated herein by reference to Exhibit 24 to   
the Schedule 13G filed by FMR LLC on January 10, 2023, accession number:        
0000315066-23-000003.                                                           

Exhibit A                                                                       

Pursuant to the instructions in Item 7 of Schedule 13G, the following table     
lists the identity and Item 3 classification, if applicable, of each relevant   
entity that beneficially owns shares of the security class being reported on    
this Schedule 13G.                                                              

Entity   ITEM 3 Classification                                                  

Fidelity Management & Research Company LLC  IA                                  
Fidelity Management Trust Company  BK                                           
IMPRESA MANAGEMENT LLC  IA                                                      

Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer  
of FMR LLC.                                                                     

Members of the Johnson family, including Abigail P. Johnson, are the            
predominant owners, directly or through trusts, of Series B voting common       
shares of FMR LLC, representing 49% of the voting power of FMR LLC. The         
Johnson family group and all other Series B shareholders have entered into a    
shareholders' voting agreement under which all Series B voting common shares    
will be voted in accordance with the majority vote of Series B voting common    
shares. Accordingly, through their ownership of voting common shares and the    
execution of the shareholders' voting agreement, members of the Johnson family  
may be deemed, under the Investment Company Act of 1940, to form a controlling  
group with respect to FMR LLC.                                                  

This filing reflects the securities beneficially owned, or that may be deemed   
to be beneficially owned, by FMR LLC, certain of its subsidiaries and           
affiliates, and other companies (collectively, the "FMR Reporters"). This       
filing does not reflect securities, if any, beneficially owned by certain       
other companies whose beneficial ownership of securities is disaggregated from  
that of the FMR Reporters in accordance with Securities and Exchange            
Commission Release No. 34-39538 (January 12, 1998).                             

RULE 13d-1(k)(1) AGREEMENT                                                      

The undersigned persons, on April 26, 2024, agree and consent to the joint      
filing on their behalf of this Schedule 13G in connection with their            
beneficial ownership of the COMMON STOCK of TURNSTONE BIOLOGICS CORP at April   
25, 2024.                                                                       

FMR LLC                                                                         

By /s/ Stephanie J. Brown                                                       
Stephanie J. Brown                                                              
Duly authorized under Power of Attorney effective as of January 3, 2023, by     
and on behalf of FMR LLC and its direct and indirect subsidiaries*              

Abigail P. Johnson                                                              

By /s/ Stephanie J. Brown                                                       
Stephanie J. Brown                                                              
Duly authorized under Power of Attorney effective as of January 26, 2023, by    
and on behalf of Abigail P. Johnson**                                           

* This power of attorney is incorporated herein by reference to Exhibit 24 to   
the Schedule 13G filed by FMR LLC on January 10, 2023, accession number:        
0000315066-23-000003.                                                           

** This power of attorney is incorporated herein by reference to Exhibit 24 to  
the Schedule 13G filed by FMR LLC on January 31, 2023, accession number:        
0000315066-23-000038.                                                           

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC 13G/A’ Filing		Date		Other Filings
Filed on:		4/29/24
		4/26/24
		4/25/24
		1/31/23		SC 13G/A
		1/26/23
		1/10/23		SC 13G,  SC 13G/A
		1/3/23
		1/12/98		SC 13G,  SC 13G/A
				List all Filings

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/23  FMR LLC                           SC 13G/A               2:10K  Charles River Labs Int’l, Inc.
 1/10/23  FMR LLC                           SC 13G/A               2:9K   Porch Group, Inc.